French Data Reassure on Bivalent COVID Booster and Stroke Risk
(MedPage Today) -- Cardiovascular events were not more likely for recipients of the Pfizer-BioNTech COVID-19 mRNA bivalent booster compared with the original monovalent booster, according to French researchers.
Their population-based study found...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news
More News: Cardiology | Cardiovascular | COVID-19 | France Health | Heart | Infectious Diseases | Pfizer | Stroke | Study